FETUB and pancreatic adenocarcinoma: In particular, the high expression of FETUB gene in tumors was significantly correlated with worse progression-free survival (PFS) rather than overall survival (OS), suggesting fetuin-B is implicated in PAAD progression and therapeutic resistance (Fig. 4A).